243 related articles for article (PubMed ID: 34644563)
21. Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections.
Gracias DT; Boesteanu AC; Fraietta JA; Hope JL; Carey AJ; Mueller YM; Kawalekar OU; Fike AJ; June CH; Katsikis PD
J Immunol; 2016 Feb; 196(3):1186-98. PubMed ID: 26740110
[TBL] [Abstract][Full Text] [Related]
22. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection.
Shin H; Blackburn SD; Intlekofer AM; Kao C; Angelosanto JM; Reiner SL; Wherry EJ
Immunity; 2009 Aug; 31(2):309-20. PubMed ID: 19664943
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-17~92 regulates effector and memory CD8 T-cell fates by modulating proliferation in response to infections.
Khan AA; Penny LA; Yuzefpolskiy Y; Sarkar S; Kalia V
Blood; 2013 May; 121(22):4473-83. PubMed ID: 23596046
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and immunological analysis of patients with activated phosphoinositide 3-kinase δ syndrome resulting from PIK3CD mutation].
Tang WJ; Wang W; Luo Y; Wang YP; Li L; An YF; Gou LJ; Ma MS; He TY; Yang J; Zhao XD; Song HM
Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):19-24. PubMed ID: 28072954
[No Abstract] [Full Text] [Related]
25. Natural Genetic Variation Reveals Key Features of Epigenetic and Transcriptional Memory in Virus-Specific CD8 T Cells.
van der Veeken J; Zhong Y; Sharma R; Mazutis L; Dao P; Pe'er D; Leslie CS; Rudensky AY
Immunity; 2019 May; 50(5):1202-1217.e7. PubMed ID: 31027997
[TBL] [Abstract][Full Text] [Related]
26. Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.
Rao VK; Webster S; Dalm VASH; Šedivá A; van Hagen PM; Holland S; Rosenzweig SD; Christ AD; Sloth B; Cabanski M; Joshi AD; de Buck S; Doucet J; Guerini D; Kalis C; Pylvaenaeinen I; Soldermann N; Kashyap A; Uzel G; Lenardo MJ; Patel DD; Lucas CL; Burkhart C
Blood; 2017 Nov; 130(21):2307-2316. PubMed ID: 28972011
[TBL] [Abstract][Full Text] [Related]
27. Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells.
Laroche-Lefebvre C; Yousefi M; Daudelin JF; Charpentier T; Tarrab E; Klinck R; Lamarre A; Labrecque N; Stäger S; Duplay P
J Immunol; 2016 Nov; 197(9):3618-3627. PubMed ID: 27664281
[TBL] [Abstract][Full Text] [Related]
28. E1021K Homozygous Mutation in PIK3CD Leads to Activated PI3K-Delta Syndrome 1.
Wang Y; Chen X; Yang Q; Tang W; Jia Y; Zhou L; An Y; Zhang Z; Tang X; Zhao X
J Clin Immunol; 2020 Feb; 40(2):378-387. PubMed ID: 31953711
[TBL] [Abstract][Full Text] [Related]
29. Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.
Asano T; Okada S; Tsumura M; Yeh TW; Mitsui-Sekinaka K; Tsujita Y; Ichinose Y; Shimada A; Hashimoto K; Wada T; Imai K; Ohara O; Morio T; Nonoyama S; Kobayashi M
Front Immunol; 2018; 9():568. PubMed ID: 29675019
[TBL] [Abstract][Full Text] [Related]
30. Dynamic Changes in Chromatin Accessibility Occur in CD8
Scott-Browne JP; López-Moyado IF; Trifari S; Wong V; Chavez L; Rao A; Pereira RM
Immunity; 2016 Dec; 45(6):1327-1340. PubMed ID: 27939672
[TBL] [Abstract][Full Text] [Related]
31. Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells.
Jensen IJ; Li X; McGonagill PW; Shan Q; Fosdick MG; Tremblay MM; Houtman JC; Xue HH; Griffith TS; Peng W; Badovinac VP
Elife; 2021 Oct; 10():. PubMed ID: 34652273
[TBL] [Abstract][Full Text] [Related]
32. Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.
Jamee M; Moniri S; Zaki-Dizaji M; Olbrich P; Yazdani R; Jadidi-Niaragh F; Aghamahdi F; Abolhassani H; Condliffe AM; Aghamohammadi A; Azizi G
Clin Rev Allergy Immunol; 2020 Dec; 59(3):323-333. PubMed ID: 31111319
[TBL] [Abstract][Full Text] [Related]
33. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
34. Signal integration by Akt regulates CD8 T cell effector and memory differentiation.
Kim EH; Sullivan JA; Plisch EH; Tejera MM; Jatzek A; Choi KY; Suresh M
J Immunol; 2012 May; 188(9):4305-14. PubMed ID: 22467649
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.
Rutishauser RL; Martins GA; Kalachikov S; Chandele A; Parish IA; Meffre E; Jacob J; Calame K; Kaech SM
Immunity; 2009 Aug; 31(2):296-308. PubMed ID: 19664941
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation.
Rao RR; Li Q; Gubbels Bupp MR; Shrikant PA
Immunity; 2012 Mar; 36(3):374-87. PubMed ID: 22425248
[TBL] [Abstract][Full Text] [Related]
37. Frontline Science: Late CD27 stimulation promotes IL-7Rα transcriptional re-expression and memory T cell qualities in effector CD8
Dong H; Buckner A; Prince J; Bullock T
J Leukoc Biol; 2019 Nov; 106(5):1007-1019. PubMed ID: 31199542
[TBL] [Abstract][Full Text] [Related]
38. STAT5 is critical to maintain effector CD8+ T cell responses.
Tripathi P; Kurtulus S; Wojciechowski S; Sholl A; Hoebe K; Morris SC; Finkelman FD; Grimes HL; Hildeman DA
J Immunol; 2010 Aug; 185(4):2116-24. PubMed ID: 20644163
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
[TBL] [Abstract][Full Text] [Related]
40. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
